A detailed history of Byrne Financial Freedom, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Byrne Financial Freedom, LLC holds 2,000 shares of ABBV stock, worth $387,020. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,000
Previous 1,900 5.26%
Holding current value
$387,020
Previous $338 Million 24.11%
% of portfolio
0.24%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025

BUY
$169.2 - $216.66 $16,920 - $21,666
100 Added 5.26%
2,000 $419 Million
Q4 2024

Apr 29, 2025

BUY
$164.99 - $203.87 $313,481 - $387,353
1,900 New
1,900 $338 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $342B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Byrne Financial Freedom, LLC Portfolio

Follow Byrne Financial Freedom, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Financial Freedom, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Financial Freedom, LLC with notifications on news.